Literature DB >> 33512495

Rapid Spread of Mutant Alleles in Worldwide SARS-CoV-2 Strains Revealed by Genome-Wide Single Nucleotide Polymorphism and Variation Analysis.

Zhenglin Zhu1, Gexin Liu1, Kaiwen Meng2, Liuqing Yang3, Di Liu4, Geng Meng2.   

Abstract

The novel coronavirus (SARS-CoV-2) has become a pandemic and is threatening human health globally. Here, we report nine newly evolved SARS-CoV-2 single nucleotide polymorphism (SNP) alleles those underwent a rapid increase (seven cases) or decrease (two cases) in their frequency for 30-80% in the initial four months, which are further confirmed by intrahost single nucleotide variation analysis using raw sequence data including 8,217 samples. The nine SNPs are mostly (8/9) located in the coding region and are mainly (6/9) nonsynonymous substitutions. The nine SNPs show a complete linkage in SNP pairs and belong to three different linkage groups, named LG_1 to LG_3. Analyses in population genetics show signatures of adaptive selection toward the mutants in LG_1, but no signal of selection for LG_2. Population genetic analysis results on LG_3 show geological differentiation. Analyses on geographic COVID-19 cases and published clinical data provide evidence that the mutants in LG_1 and LG_3 benefit virus replication and those in LG_1 have a positive correlation with the disease severity in COVID-19-infected patients. The mutants in LG_2 show a bias toward mildness of the disease based on available public clinical data. Our findings may be instructive for epidemiological surveys and disease control of COVID-19 in the future.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; SNP; iSNV; mutants

Year:  2021        PMID: 33512495     DOI: 10.1093/gbe/evab015

Source DB:  PubMed          Journal:  Genome Biol Evol        ISSN: 1759-6653            Impact factor:   3.416


  8 in total

1.  Characterisation of SARS-CoV-2 clades based on signature SNPs unveils continuous evolution.

Authors:  Nimisha Ghosh; Indrajit Saha; Suman Nandi; Nikhil Sharma
Journal:  Methods       Date:  2021-09-20       Impact factor: 4.647

Review 2.  Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review.

Authors:  SeyedAhmad SeyedAlinaghi; Pegah Mirzapour; Omid Dadras; Zahra Pashaei; Amirali Karimi; Mehrzad MohsseniPour; Mahdi Soleymanzadeh; Alireza Barzegary; Amir Masoud Afsahi; Farzin Vahedi; Ahmadreza Shamsabadi; Farzane Behnezhad; Solmaz Saeidi; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-06-08       Impact factor: 2.175

3.  Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.

Authors:  Haibo Wu; Na Xing; Kaiwen Meng; Beibei Fu; Weiwei Xue; Pan Dong; Wanyan Tang; Yang Xiao; Gexin Liu; Haitao Luo; Wenzhuang Zhu; Xiaoyuan Lin; Geng Meng; Zhenglin Zhu
Journal:  Cell Host Microbe       Date:  2021-11-13       Impact factor: 21.023

4.  Identifying SARS-CoV-2 Lineage Mutation Hallmarks and Correlating Them With Clinical Outcomes in Egypt: A Pilot Study.

Authors:  Sara H A Agwa; Hesham Elghazaly; Mahmoud Shawky El Meteini; Yahia A Yahia; Radwa Khaled; Aya M Abd Elsamee; Reham M Darwish; Shaimaa M Elsayed; Hala Hafez; Basma S Mahmoud; Fouda Em; Marwa Matboli
Journal:  Front Mol Biosci       Date:  2022-03-08

5.  Mutations and Phylogenetic Analyses of SARS-CoV-2 Among Imported COVID-19 From Abroad in Nanjing, China.

Authors:  Ning Zhao; Nan Zhou; Huafeng Fan; Jie Ding; Xingyu Xu; Xiaoqing Dong; Xiaoxiao Dong; Dandan Xu; Xiaoyu Min; Yan Yu; Hongjin Gong; Lingfeng Mao; Min He
Journal:  Front Microbiol       Date:  2022-03-17       Impact factor: 5.640

6.  Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.

Authors:  Sonia Aparecida Andrade; João Victor Batalha-Carvalho; Rui Curi; Fan Hui Wen; Dimas Tadeu Covas; Ana Marisa Chudzinski-Tavassi; Ana Maria Moro
Journal:  Front Immunol       Date:  2022-07-11       Impact factor: 8.786

Review 7.  SARS-COV-2 Variants: Differences and Potential of Immune Evasion.

Authors:  Sandro M Hirabara; Tamires D A Serdan; Renata Gorjao; Laureane N Masi; Tania C Pithon-Curi; Dimas T Covas; Rui Curi; Edison L Durigon
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

8.  CovDif, a Tool to Visualize the Conservation between SARS-CoV-2 Genomes and Variants.

Authors:  Luis F Cedeño-Pérez; Laura Gómez-Romero
Journal:  Viruses       Date:  2022-03-09       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.